With funding from the National Institutes of Health, Dr. Eng undertook
an ambitious clinical research study to determine for who should be tested for PTEN mutations, and what cancer surveillance strategies should be used for affected individuals.
The
Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative basic science in tumor immunology, enables experts to advance their most ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not d
Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative basic science in tumor immunology, enables experts to advance their most
ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not d
clinical and translational
research ideas to cure cancer, and accelerates
studies that one group or company could not do alone.
Clinical Accelerator fosters a collaborative environment that enables scientists to advance their most ambitious clinical and translational research ideas, and accelerates studies that one group or company could not d
Clinical Accelerator fosters a collaborative environment that enables scientists to advance their most
ambitious clinical and translational research ideas, and accelerates studies that one group or company could not d
clinical and translational
research ideas, and accelerates
studies that one group or company could not do alone.